Reemplazo valvular aórtico transcatéter (RVAT): manejo perioperatorio y consideraciones anestésicas / Transcathether aortic valve replacement (TAVR): perioperative management and anesthetic considerations

The trans-catheter aortic valve replacement (TAVR) is becoming more frequent and, therefore, there is need for a proper perioperative management. The new devices have reduced the complications and therefore increased the indications of this technique, even in patients with low surgical risk. It is necessary to know the procedure and the types of valves available, the most frequent access is transfemoral and the devices are usually separated in ballon-expandable and self-expanding valves. There is recent evidence that would indicate some benefits of using sedation as the anesthetic technique, however, the choice should be based on each individual patient, the center and the experience of each anesthesiologist in charge. Although TAVR is much safer today, there are multiple complications reported, such as vascular lesions, paravalvular leakage, neurological complications, among others. An adequate knowledge and monitoring of them will allow us to reduce them in the perioperative period.

Cada vez es más frecuente el reemplazo valvular aórtico trans-catéter (RVAT) y, por ende, la necesidad de su adecuado manejo perioperatorio. Los nuevos dispositivos han disminuido sus complicaciones y, por lo tanto, aumentado su indicación, incluso en pacientes de bajo riesgo quirúrgico. Es necesario conocer la forma en que se realiza el procedimiento, tipos de válvulas disponibles, accesos más frecuentes y los tipos de dispositivos. Existe evidencia reciente que indicaría algunos beneficios de utilizar sedación como técnica anestésica, sin embargo, la elección se debe basar en cada paciente en particular, el centro y la experiencia de cada anestesiólogo a cargo. Si bien el RVAT hoy es mucho más seguro, existen complicaciones, entre las que se encuentran lesiones vasculares, leak paravalvular, complicaciones neurológicas, tamponamiento, entre otras. Un adecuado conocimiento y monitorización de ellas nos permitirá reducirlas en el perioperatorio.

Normas de comportamiento en salud y guías clínicas: del escrito a la aplicación / Standards of behavior in health and clinical guidelines: from writing to the application

The adverse event in health continues to be an important cause of morbidity. Since the emergence of the safety culture, institutions, associations and collegiate bodies have been dedicated to the construction of standards, guidelines and protocols to improve patient safety, including adopting procedures and habits in an eclectic manner, from other professions and occupations. However, the human factor continues to be a frequent cause of adverse events, so it is worth reviewing some aspects of human behavior that help implement measures that reduce the gap between follow-up records of completed guidelines and actions actually carried out as a result of the adherence and implementation of clinical practice guidelines.

El evento adverso en salud sigue siendo una causa importante de morbilidad. Desde la aparición de la cultura de seguridad, las instituciones, agremiaciones y cuerpos colegiados se han dedicado a la construcción de normas, guías y protocolos para mejorar la seguridad de los pacientes, incluso, adoptando procedimientos y hábitos de manera ecléctica, provenientes de otras profesiones y ocupaciones. Sin embargo, el factor humano sigue siendo una causa frecuente de eventos adversos, por lo cual vale la pena revisar algunos aspectos del comportamiento humano que ayuden a implementar medidas que disminuyan la brecha entre registros de seguimiento de guías diligenciadas y acciones efectivamente ejecutadas como consecuencia de la adherencia e implementación de guías de práctica clínica.

Toward reliable population estimates of wolves by combining spatial capture-recapture models and non-invasive DNA monitoring.

Decision-makers in wildlife policy require reliable population size estimates to justify interventions, to build acceptance and support in their decisions and, ultimately, to build trust in managing authorities. Traditional capture-recapture approaches present two main shortcomings, namely, the uncertainty in defining the effective sampling area, and the spatially-induced heterogeneity in encounter probabilities. These limitations are overcome using spatially explicit capture-recapture approaches (SCR). Using wolves as case study, and non-invasive DNA monitoring (faeces), we implemented a SCR with a Poisson observation model in a single survey to estimate wolf density and population size, and identify the locations of individual activity centres, in NW Iberia over 4,378 km2. During the breeding period, posterior mean wolf density was 2.55 wolves/100 km2 (95%BCI = 1.87-3.51), and the posterior mean population size was 111.6 ± 18.8 wolves (95%BCI = 81.8-153.6). From simulation studies, addressing different scenarios of non-independence and spatial aggregation of individuals, we only found a slight underestimation in population size estimates, supporting the reliability of SCR for social species. The strategy used here (DNA monitoring combined with SCR) may be a cost-effective way to generate reliable population estimates for large carnivores at regional scales, especially for endangered species or populations under game management.

Nuevos anticoagulantes orales y antiagregantes plaquetarios, en el período perioperatorio de cirugía no cardíaca. Parte 1: Nuevos anticoagulantes directos / Novel oral anticoagulants and new platelet antiaggregants, in the perioperative period of non cardiac surgery. Part 1: New direct oral anticoagulants

Due to the high frequency of patients with atrial fibrillation, thromboembolic disease, users of mechanical prosthetic valves, among other pathologies, in addition to their established use and advantages over vitamin K inhibitors, the use of novel oral anticoagulants (NOAC) is becoming more frequent in the perioperative period. The anesthesiologist must consider the thromboembolic risk of the patient, risk of bleeding, the half-life of the NOAC in used, in addition to the patients renal and hepatic function. Rivaroxaban and Apixaban should be suspended according to the risk of surgical bleeding, 24 to 36 hours before a surgery with a low risk of bleeding and 48 hours for high. In the case of Dabigatran, these times should be extended. These drugs are safe in the perioperative period and in most cases, it is not necessary to do a bridging therapy with heparin. The reversal of this type of drugs is also of special interest, currently available with specific methods for dabigatrán. Antidotes for other drugs are being studied. The decision of using a neuraxial block should be evaluated according to the time in which the patient discontinued the drugs and their renal function, specially in the case of Dabigatran.

Por la alta frecuencia de pacientes con fibrilación auricular, enfermedad tromboembólica, usuarios de válvulas protésicas mecánicas, entre otras patologías, además, de su establecido uso y ventajas con respecto a los inhibidores de vitamina K, cada vez es más frecuente el uso de los nuevos anticoagulantes orales (NACO) en el perioperatorio. Su manejo tiene características especiales. Debemos considerar el riesgo tromboembólico del paciente, de sangrado, la vida media del NACO utilizado, además de las funciones depurativas del organismo. Rivaroxaban y apixaban deben ser suspendidos según el riesgo de sangrado quirúrgico, 24 a 36 horas previo a una cirugía de bajo riesgo de sangrado y 48 horas para una de alto riesgo. En el caso del Dabigatrán y por la importancia de la función renal en su eliminación, estos tiempos deben extenderse. Estos fármacos son seguros en el perioperatorio y en la mayor parte de los casos no es necesario hacer terapia puente con heparina. La reversión es también de especial interés. Actualmente, se dispone con métodos específicos para dabigatrán y potenciales antídotos para los otros fármacos. La posibilidad de realizar un bloqueo neuroaxial debe ser evaluado según el tiempo en que el paciente suspendió los medicamentos y su función renal en caso de Dabigatrán.

Nuevos anticoagulantes orales y antiagregantes plaquetarios, en el período perioperatorio de cirugía no cardíaca. Parte 2: Nuevos antiagregantes plaquetarios / Novel oral anticoagulants and new platelet antiaggregants, in the perioperative period of non cardiac surgery. Part 2: New platelet antiaggregants

Coronary disease and the cerebro-vascular accidents represent the first causes of mortality worldwide. Platelet antiaggregants are fundamental for the management and prevention of these diseases. Aspirin is still the most used drug in this group, but new antagonists of the ADP receptor and glycoprotein IIb/IIIa antagonists have been added with increasing frequency, so its management in the perioperative period deserves special attention. There are clinical guidelines that help us decide on the maintenance or suspension of these drugs in the perioperative period, all of which are based mainly on expert recommendations and state that the decision should be taken jointly by the entire treatment team. If their antiplatelet effects are not desired, Clopidogrel and Ticagrelor should be discontinued at least 5 days before surgery, and at least 7 days with Prasugrel. Cangrelor should be discontinued at least 60 minutes prior to the procedure. After the suspension of glycoprotein IIb/IIIa inhibitors, platelet activity returns to normal at 8 hours with Tirofiban and Eptifibatide, and up to 24 to 48 hours with Abciximab. There are also recommendations regarding the use of neuroaxial anesthesia in patients who use this type of drug.

La enfermedad coronaria y el accidente cerobrovascular representan las primeras causas de mortalidad a nivel mundial. Los antiagregantes plaquetarios, son fundamentales para el manejo y prevención de estas enfermedades. La Aspirina sigue siendo el fármaco más utilizado de este grupo, pero se han ido agregando nuevos antagonistas del receptor de ADP y antagonistas de la Glicoproteína IIb/IIIa con cada vez mayor frecuencia, por lo que su manejo en el perioperatorio merece atención especial. Existen guías clínicas que nos ayudan a decidir la mantención o suspensión de estos fármacos en el perioperatorio, todas ellas son basadas principalmente en recomendaciones de expertos y recomiendan que la decisión sea tomada en conjunto por todo el equipo tratante. Si se quiere suspender estos fármacos y evitar sus efectos antiplaquetarios, clopidogrel y ticagrelor se deben suspender al menos 5 días previo a la cirugía, y al menos 7 días en el caso de prasugrel. Cangrelor se debe suspender al menos 60 minutos previo al procedimiento. Luego de la suspensión de los inhibidores de glicoproteína IIb/IIIa, la actividad plaquetaria vuelve a la normalidad a las 8 horas en el caso de tirofiban y eptifibatide, y hasta 24 a 48 horas en el caso de abciximab. Existen también recomendaciones con respecto al uso de anestesia neuroaxial en los pacientes usuarios de este tipo de fármacos.

De la farmacocinética a la farmacodinámica, ¿estamos listos para los software 3D? / From pharmacokinetics to pharmacodynamics -Are we ready for 3D software?

Abstract The relationship between the dose and plasma concentration of a drug is determined by pharmacokinetics. However, difficulties arise when more than one drug is administered simultaneously. There is currently a gap in the teaching model when trying to convey the significance of pharmacodynamic interactions. In this article the authors reflect on the importance of developing a software that simplifies the pharmacokinetic concepts of two drugs, turning them into one single variable in space as a function of time. Together with depth of anesthesia monitoring and the pain control variables, this model will bring pharmacokinetics and pharmacodynamics together and provide a teaching tool for improved understanding of these concepts.

Resumen La relación entre la dosis y la concentración plasmática de un fármaco está determinada por la farmacocinética. Sin embargo, se presentan dificultades cuando hay más de un medicamento administrado de forma simultánea. En la actualidad hay un vacío en el modelo de enseñanza cuando se pretende difundir la importancia de las interacciones farmacodinámicas. En el presente artículo los autores hacen una reflexión sobre la importancia de poder construir un software que simplifique los conceptos farmacocinéticos de dos medicamentos, convirtiéndolos en una sola variable de espacio en función del tiempo. Este modelo permitiría, junto con la monitorización de la profundidad anestésica y las variables de control del dolor, acoplar la farmacocinética a la farmacodinámica, y brindaría una herramienta de educación para la comprensión de estos conceptos.

Spatial assessment of wolf-dog hybridization in a single breeding period.

Understanding the dynamics of wolf-dog hybridization and delineating evidence-based conservation strategies requires information on the spatial extent of wolf-dog hybridization in real-time, which remains largely unknown. We collected 332 wolf-like scats over ca. 5,000km2 in the NW Iberian Peninsula to evaluate wolf-dog hybridization at population level in a single breeding/pup-rearing season. Mitochondrial DNA (MtDNA) and 18 ancestry informative markers were used for species and individual identification, and to detect wolf-dog hybrids. Genetic relatedness was assessed between hybrids and wolves. We identified 130 genotypes, including 67 wolves and 7 hybrids. Three of the hybrids were backcrosses to dog whereas the others were backcrosses to wolf, the latter accounting for a 5.6% rate of introgression into the wolf population. Our results show a previously undocumented scenario of multiple and widespread wolf-dog hybridization events at the population level. However, there is a clear maintenance of wolf genetic identity, as evidenced by the sharp genetic identification of pure individuals, suggesting the resilience of wolf populations to a small amount of hybridization. We consider that real-time population level assessments of hybridization provide a new perspective into the debate on wolf conservation, with particular focus on current management guidelines applied in wolf-dog hybridization events.

Laminin isoforms in endothelial and perivascular basement membranes.

Laminins, one of the major functional components of basement membranes, are found underlying endothelium, and encasing pericytes and smooth muscle cells in the vessel wall. Depending on the type of blood vessel (capillary, venule, postcapillary venule, vein or artery) and their maturation state, both the endothelial and mural cell phenotype vary, with associated changes in laminin isoform expression. Laminins containing the α4 and α5 chains are the major isoforms found in the vessel wall, with the added contribution of laminin α2 in larger vessels. We here summarize current data on the precise localization of these laminin isoforms and their receptors in the different layers of the vessel wall, and their potential contribution to vascular homeostasis.

Guía para la intubación con fibrobroncoscopio en un Hospital Universitario / Guidelines for intubation under fiberoptic bronchoscopy in a University Hospital

Introducción: El recurso del fibrobroncoscopio como instrumento para la intubación traqueal es relativamente reciente en nuestro medio. Su disponibilidad es cada vez mayor y por ello los anestesiólogos deben entrenarse suficientemente en el uso de este equipo. Conocer y dominar una técnica, respetando cada uno de sus pasos, es el primer paso para la realización exitosa de un procedimiento. Objetivo: En la presente guía se describe la técnica utilizada en para la intubación con Intubaciónfibrobroncoscopio en el Hospital Universitario del Valle Evaristo García. Metodología: El artículo se basa en la revisión de la literatura, la experiencia de los autores y un foro de discusión. Resultados: Se presenta la guía para la intubación con fibrobroncoscopio en el Hospital Universitario del Valle Evaristo García. Se describe la técnica para la construcción de una máscara para la ventilación del paciente durante el procedimiento de intubación traqueal con la utilización del fibrobroncoscopio.

Introduction: The use of fiberoptic bronchoscopy as a tool for tracheal intubation is relatively new in our setting. Its availability has been increasing, and hence the need for anesthetists to receive adequate training in the use of this device. Knowledge and mastery of this technique, following all the necessary steps, is the starting point for the successful performance of a procedure. Objective: These guidelines describe the technique for intubation using the fiberoptic bronchoscope at the Evaristo García University Hospital of the Colombian Department of Valle. Methodology: This paper is based on a review of the literature, the authors' experience, and a discussion forum. Results: Presentation of the guidelines for intubation using fiber optic bronchoscope at the Evaristo García University Hospital. Description of the technique for constructing a mask for patient ventilation during tracheal intubation under fiberoptic bronchoscopy.

Stents coronarios y cirugía no cardiaca: estrategias de manejo actual / Coronary stents and non-cardiac surgery: current management strategies

The care of patients with coronary stents in the perioperative period of non-cardiac surgery requires anesthesiologists, surgeons and cardiologists. The management of dual antiplatelet therapy should be handled depending on type and urgency of the surgery, the risk of bleeding, type of coronary stent implanted, time from placement and the risk of stent thrombosis. For patients identified as high risk of stent thrombosis, surgery should be planned at hospitals with cardiac catheterization facilities. These patients require postoperative monitoring and antiplatelet therapy should be restarted immediately. Stent thrombosis should be recognized early and treated aggressively with percutaneous coronary intervention.

[Current management strategies for pulmonary hypertension in surgical patients]. / Hipertensión pulmonar y el paciente quirúrgico: estrategias de manejo actual.

Pulmonary hypertension is a clinical condition with a low prevalence, but carries high morbidity and mortality. Important advances in the understanding of this disease and in its therapy have occurred. A particular scenario is pulmonary hypertension in patients undergoing non-cardiac as well as cardiac surgery. The aim of this review is to present information that may allow diagnostic and therapeutic approaches of this clinical condition in patients undergoing surgery.

Hipertensión pulmonar y el paciente quirúrgico: estrategias de manejo actual / Current management strategies for pulmonary hypertension in surgical patients

Pulmonary hypertension is a clinical condition with a low prevalence, but carries high morbidity and mortality. Important advances in the understanding of this disease and in its therapy have occurred. A particular scenario is pulmonary hypertension in patients undergoing non-cardiac as well as cardiac surgery. The aim of this review is to present information that may allow diagnostic and therapeutic approaches of this clinical condition in patients undergoing surgery.

Mitochondria-penetrating peptides: sequence effects and model cargo transport.

A class of mitochondria-penetrating peptides (MPPs) was studied in an effort to optimize their applications in the delivery of bioactive cargo to this therapeutically important organelle. The sequence requirements for mitochondrial entry were monitored, and it was discovered that while an alternating cationic/hydrophobic residue motif is not required, the inclusion of a stretch of adjacent cationic amino acids can impede access to the organelle. In addition, a variety of N- and C-terminal cargo were tested to determine if there are limitations to the lipophilicity, charge, or polarity of compounds that can be transported to mitochondria by MPPs. The results reported demonstrate that these peptide sequences are versatile transporters that will have a range of biological applications.

Targeting mitochondria with organelle-specific compounds: strategies and applications.

Mitochondria are the energy factories of the cell and also serve as a checkpoint regulating programmed cell death. Not surprisingly, dysfunctional mitochondria are implicated in a variety of diseases ranging from metabolic disorders to cancer. Treatment of these diseases through the delivery of targeted drugs, however, is impeded by the difficulty of penetrating the membranes that define this organelle. The properties of this barrier serve as a major obstacle to drug delivery and a lack of effective transporters has hindered the advancement of mitochondrial medicine. Recently, however, synthetic transporters that show promise for the mito-specific delivery of bioactive cargos have begun to emerge. This review summarizes the most exciting of these developments and discusses their applications.

Uso de factor VII en el control de sangrados perioperatorios: evidencias actuales / Recombinant activated factor VII for perioperative bleeding

Recombinant activated factor VII (rFVIIa) is a new haemostatic drug, originally used for the treatment of patients with hemophilia A and B. At the present time it is used for other bleeding conditions such as the perioperative period. When used prophylactically there is a reduction in the number of bleeding episodes but no changes in the need for blood transfusion or other blood products. The adverse effects are arterial or venous thromboembolic events that are mostly related to the severity of the underlying disease of the patient and the concurrent administration of other haemostatic agents, rather than the use of rFVIIa. Its use is recommended when there is a persistent bleeding after the reposition of blood products and when surgical causes of bleeding have been discarded. The cost of the medication should also be considered before its use.

[Massive tricuspid valve insufficiency after blunt chest trauma: report of one case]. / Rotura de válvula tricúspide con insuficiencia masiva secundaria a traumatismo torácico cerrado: Caso clínico.

Cardiac valve lesions after a blunt chest trauma are rare and less than 1% of cardiac lesions because of chest trauma affect the tricuspid valve. We report a 70 year-old female that suffered a severe chest trauma in a car accident. During the repair of the multiple skeletal lesions, the patient had a severe hemodynamic decompensation. A myocardial trauma with pericardial effusion and massive tricuspid insufficiency, due to anterior leaflet prolapse, was diagnosed on echocardiography. After discharge the patient remained in functional class II, with hepatomegaly, jugular ingurgitation and lower limb edema. A control echocardiogram, performed six months after the accident, showed dilatation of right heart chambers and massive tricuspid insufficiency. The patient was operated, and a tricuspid valve repair was performed suturing the ruptured papillary muscle to the ventricular wall and performing a tricuspid annuloplasty with a prosthetic ring. After 15 months of follow up, the patient remains asymptomatic.